期刊文献+

Management of centrally located hepatocellular carcinoma:Update 2016 被引量:18

Management of centrally located hepatocellular carcinoma:Update 2016
下载PDF
导出
摘要 Centrally located hepatocellular carcinoma(HCC)is sited in the central part of the liver and adjacent to main hepatic vascular structures.This special location is associated with an increase in the difficulty of surgery,aggregation of the recurrence disease,and greater challenge in disease management.This review summarizes the evolution of our understanding for centrally located HCC and discusses the development of treatment strategies,surgical approaches and recurrence prevention methods.To improve patient survival,a multi-disciplinary modality is greatly needed throughout the whole treatment period. Centrally located hepatocellular carcinoma (HCC) is sited in the central part of the liver and adjacent to main hepatic vascular structures. This special location is associated with an increase in the difficulty of surgery, aggregation of the recurrence disease, and greater challenge in disease management. This review summarizes the evolution of our understanding for centrally located HCC and discusses the development of treatment strategies, surgical approaches and recurrence prevention methods. To improve patient survival, a multi-disciplinary modality is greatly needed throughout the whole treatment period.
出处 《World Journal of Hepatology》 CAS 2017年第13期627-634,共8页 世界肝病学杂志(英文版)(电子版)
关键词 Centrally located hepatocellular carcinoma HEPATECTOMY Combined treatment Hepatic vascular occlusion Centrally located hepatocellular carcinoma Hepatectomy Combined treatment Hepatic vascular occlusion
  • 相关文献

参考文献11

二级参考文献89

  • 1Wan-Yee Lau,Eric C.H.Lai,Stephanie H.Y.Lau.Methods of vascular control technique during liver resection:a comprehensive review[J].Hepatobiliary & Pancreatic Diseases International,2010,9(5):473-481. 被引量:27
  • 2Rajagopal N Aravalli.Role of innate immunity in the development of hepatocellular carcinoma[J].World Journal of Gastroenterology,2013,19(43):7500-7514. 被引量:8
  • 3韩克起,顾伟,苏永华,黄雪强,王喜,凌昌全.蟾毒灵抗小鼠原位移植性肝癌整体药效学研究[J].中华实验外科杂志,2004,21(12):1436-1438. 被引量:12
  • 4Rong Tu,Li-Ping Xia,An-Le Yu,Ling Wu.Assessment of hepatic functional reserve by cirrhosis grading and liver volume measurement using CT[J].World Journal of Gastroenterology,2007,13(29):3956-3961. 被引量:21
  • 5Jemal A,Bray F,Center MM,Ferlay J Ward E Forman D. Global cancer statistics[J].CA:A Cancer Journal for Clinicians,2011,(02):69-90.
  • 6Ferlay J,shin HR,Bray F,Forman D,Mathers C,Parkin DM. GLOBOCAN 2008:Cancer incidence and mortality worldwide:IARC CancerBase No.10[OL].http://www.iarc.fr/en/media-centre/iarcnews/2010/globocan2008.php,2011.
  • 7Ercolani G,Grazi GL,Ravaioli M,Del Gaudio M Gardini A Cescon M Varotti G Cetta F Cavallari A. Liver resection for hepatocellular carcinoma on cirrhosis:univariate and multivariate analysis of risk factors for intrahepatic recurrence[J].Annals of Surgery,2003,(04):536-543.
  • 8Bruix J,Sherman M,Practice Guidelines Committee,American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma[J].Hepatology,2005,(05):1208-1236.doi:10.1002/hep.20933.
  • 9Imamura H,Matsuyama Y,Tanaka E,Ohkubo T Hasegawa K Miyagawa S Sugawara Y Minagawa M Takayama T Kawasaki S Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy[J].Journal of Hepatology,2003,(02):200-207.
  • 10Poon RT,Fan ST,Lo CM,Liu CL Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function:implications for a strategy of salvage transplantation[J].Annals of Surgery,2002,(03):373-382.

共引文献173

同被引文献96

引证文献18

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部